Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Accumulated Depreciation (2020 - 2023)

Historic Accumulated Depreciation for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $1.8 million.

  • Candel Therapeutics' Accumulated Depreciation rose 10242.02% to $1.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.8 million, marking a year-over-year increase of 10242.02%. This contributed to the annual value of $1.1 million for FY2022, which is 22073.86% up from last year.
  • Latest data reveals that Candel Therapeutics reported Accumulated Depreciation of $1.8 million as of Q3 2023, which was up 10242.02% from $1.6 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Accumulated Depreciation ranged from a high of $1.8 million in Q3 2023 and a low of $134000.0 during Q4 2020
  • In the last 4 years, Candel Therapeutics' Accumulated Depreciation had a median value of $704000.0 in 2022 and averaged $808545.5.
  • As far as peak fluctuations go, Candel Therapeutics' Accumulated Depreciation skyrocketed by 38351.06% in 2022, and later surged by 10242.02% in 2023.
  • Candel Therapeutics' Accumulated Depreciation (Quarter) stood at $134000.0 in 2020, then soared by 162.69% to $352000.0 in 2021, then soared by 220.74% to $1.1 million in 2022, then surged by 62.98% to $1.8 million in 2023.
  • Its Accumulated Depreciation stands at $1.8 million for Q3 2023, versus $1.6 million for Q2 2023 and $1.4 million for Q1 2023.